Gennev, MD-Led Platform

Gennev is a Seattle-founded menopause telehealth company that launched in 2016, making it one of the earliest platforms dedicated specifically to virtual menopause care at a time when the category barely existed. The company was built around a clinical conviction that menopause is a distinct medical specialty — not a side topic in a general OB/GYN practice — and that the physicians managing it should have specific training and certification beyond their standard board preparation. Gennev's clinical network is composed of board-certified OB/GYNs, many of whom hold additional credentials from the Menopause Society (formerly the North American Menopause Society), the professional body that certifies clinicians in evidence-based menopause medicine. This focus on physician-level credentials differentiates Gennev from platforms that staff primarily with nurse practitioners or physician assistants, and reflects the company's positioning as a clinical-grade service rather than a direct-to-consumer supplement or wellness brand. The platform's care model is what Gennev calls Integrated Menopause Care — an approach that positions the patient-doctor relationship at the center but supplements it with registered dietitian nutritionists and health coaches when clinically indicated. Research on menopause outcomes consistently shows that hormone therapy works best when combined with lifestyle interventions around sleep, stress management, nutrition, and weight, and Gennev's team structure reflects this evidence. Gennev accepts insurance through partnerships with Aetna, Anthem, and United Healthcare, with coverage extended to all 50 states and the District of Columbia. The company has been public about its goal of making menopause care as normalized and accessible as any other specialty visit, and the insurance partnerships are central to that goal: they remove the cash-pay barrier that has historically made menopause telehealth a service primarily accessible to higher-income women. Clinicians on the platform prescribe the full range of evidence-based menopause treatments: systemic estrogen (patches, gels, creams, rings, and oral tablets), progesterone (micronized oral and IUD), local vaginal estrogen, and non-hormonal prescription options including SSNRIs for vasomotor symptoms. The platform does not prescribe compounded or unregulated hormone preparations. For patients who want a physician-led, insurance-supported menopause care experience with a clinical team that has been specifically trained for this phase of life, Gennev represents one of the most established options in the category. The company was built around a clinical conviction that menopause is a distinct medical specialty — not a side topic in a general OB/GYN practice — and that the physicians managing it should have specific training and certification beyond their standard board preparation. Gennev's clinical network is composed of board-certified OB/GYNs, many of whom hold additional credentials from the Menopause Society (formerly the North American Menopause Society), the professional body that certifies clinicians in evidence-based menopause medicine. This focus on physician-level credentials differentiates Gennev from platforms that staff primarily with nurse practitioners or physician assistants, and reflects the company's positioning as a clinical-grade service rather than a direct-to-consumer supplement or wellness brand. The platform's care model is what Gennev calls Integrated Menopause Care — an approach that positions the patient-doctor relationship at the center but supplements it with registered dietitian nutritionists and health coaches when clinically indicated. Research on menopause outcomes consistently shows that hormone therapy works best when combined with lifestyle interventions around sleep, stress management, nutrition, and weight, and Gennev's team structure reflects this evidence. Gennev accepts insurance through partnerships with Aetna, Anthem, and United Healthcare, with coverage extended to all 50 states and the District of Columbia. The company has been public about its goal of making menopause care as normalized and accessible as any other specialty visit, and the insurance partnerships are central to that goal: they remove the cash-pay barrier that has historically made menopause telehealth a service primarily accessible to higher-income women. Clinicians on the platform prescribe the full range of evidence-based menopause treatments: systemic estrogen (patches, gels, creams, rings, and oral tablets), progesterone (micronized oral and IUD), local vaginal estrogen, and non-hormonal prescription options including SSNRIs for vasomotor symptoms. The platform does not prescribe compounded or unregulated hormone preparations. For patients who want a physician-led, insurance-supported menopause care experience with a clinical team that has been specifically trained for this phase of life, Gennev represents one of the most established options in the category.